Market news

Earlier in 2026, Masimo voluntarily initiated global Class II recalls of certain Radius VSM ECG assemblies and blood pressure cuffs after identifying risks of false heart-rate alarms and potential skin irritation from rough cuff edges, affecting more than 1,800 devices distributed across the US and multiple international markets. Because these issues touch core patient-monitoring functions that clinicians rely on, the recalls raise meaningful questions about product reliability, regulatory...

Masimo (MASI) has drawn fresh investor attention after voluntarily recalling specific Radius VSM disposable blood pressure cuffs and ECG pre connected sets, citing possible ECG alarm inaccuracies and skin irritation risks across a globally distributed inventory. See our latest analysis for Masimo. Set against the recent recall headlines, Masimo’s share price return of 41.25% year to date and 2.55% over 90 days suggests investors are still pricing in improving sentiment, even though the 5 year...

Danaher, which released its Q2 2026 results on 21 July, saw expectations firm up ahead of the report as analysts projected modest year-on-year growth in revenue and earnings, helped by solid bioprocessing demand, improved filtration activity, and contributions from the Masimo acquisition despite cost pressures and higher debt. Investors are focusing on how Masimo’s integration and continued strength in bioprocessing and diagnostics could offset weaker areas like Diagnostics and rising input,...

Apple says OpenAI stole its trade secrets. Here's how Apple has faced similar accusations from rivals in the past.